Nalaganje...
Initial Testing (Stage 1) of the Polo-Like Kinase Inhibitor Volasertib (BI 6727), by the Pediatric Preclinical Testing Program
BACKGROUND: Volasertib (BI 6727) is a potent inhibitor of Polo-like kinase 1 (Plk1), that is overexpressed in several childhood cancers and cell lines. Because of its novel mechanism of action, volasertib was evaluated through the PPTP. PROCEDURES: Volasertib was tested against the PPTP in vitro cel...
Shranjeno v:
| izdano v: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4241497/ https://ncbi.nlm.nih.gov/pubmed/23956067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24616 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|